A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge
Clinical trial NCT05884242 · COMPLETED
Trial details
- NCT number
- NCT05884242
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-22
- Primary completion
- 2023-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.